Richard Bright

Dr Richard Bright is a Research Fellow at the Biomedical Nanoengineering Laboratory in the College of Medicine and Public Health, Flinders University, and at the Flinders Health and Medical Research Institute (FHMRI). His research focuses on developing advanced biomaterials and surface-engineering techniques for wound healing, cardiovascular devices, and implantable medical devices, with particular focus on applications in diabetes and cardiometabolic disease.

His work investigates how chronic low-grade inflammation, immune dysregulation, oxidative stress, and advanced glycation end product (AGE)-modified proteins influence blood–biomaterial and tissue–biomaterial interactions. These pathological factors play a major role in impaired healing, infection susceptibility, and implant failure in high-risk patient populations. Through a combination of biomaterials science, microbiology, cell and molecular biology, and immunology, Dr Bright studies how bacteria, immune cells, and mammalian cells respond to engineered biomaterial surfaces under diabetic and inflammatory conditions.

A major focus of his research is the design of antimicrobial and immunomodulatory biomaterial coatings that can reduce bacterial colonisation, minimise maladaptive inflammatory responses, and improve tissue integration and long-term device performance. His work integrates advanced in vitro disease models, surface characterisation, molecular and cellular analysis, and translational biomedical engineering approaches to address clinically relevant challenges in cardiovascular and regenerative medicine

Dr Bright also has extensive translational research experience gained through previous research-focused initiatives in stem cell biology and cancer research. This background has provided expertise in advanced cell-based assays, biomaterial evaluation, preclinical research, and multidisciplinary collaboration across academic, clinical, and industry sectors

At Flinders University, Dr Bright is actively involved in collaborative and interdisciplinary research spanning biomaterials, infection biology, immune modulation, regenerative medicine, and nanotechnology. He is passionate about mentoring emerging researchers and is currently open to supervising motivated Honours, Master’s, and PhD students interested in biomaterials, microbiology, cardiovascular devices, antimicrobial surfaces, tissue engineering, and host–pathogen interactions

Prospective students will have the opportunity to work on clinically relevant projects involving:

Biomaterial surface engineering and plasma polymer coatings

Antimicrobial and anti-inflammatory implant technologies

Diabetes-associated implant complications

Host immune responses to biomaterials

Biofilm formation and infection prevention

Advanced cell culture and molecular biology techniques

Translational cardiovascular and orthopaedic biomaterials research

Students joining the Biomedical Nanoengineering Laboratory at Flinders University will be part of a highly collaborative environment with access to state-of-the-art facilities and opportunities to work alongside clinicians, engineers, cell biologists, microbiologists, and industry partners on projects with strong translational and clinical impact.